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ABSTRACT
Objectives: We investigated the long-term impact of early childhood malaria prophylaxis on
cognitive and educational outcomes.
Design: This was a household-based cluster-controlled intervention trial.
Setting: The study was conducted in 15 villages situated between 32 km to the east and 22
km to the west of the town of Farafenni, the Gambia, on the north bank of the River Gambia.
Participants: A total of 1,190 children aged 3–59 mo took part in the trial. We traced 579 trial
participants (291 in the prophylaxis group and 288 in the placebo group) in 2001, when their
median age was 17 y 1 mo (range 14 y 9 mo to 19 y 6 mo).
Interventions: Participants received malaria chemoprophylaxis (dapsone/pyrimethamine) or
placebo for between one and three malaria transmission seasons from 1985 to 1987 during the
controlled trial. At the end of the trial, prophylaxis was provided for all children under 5 y of age
living in the study villages.
Outcome Measures: The outcome measures were cognitive abilities, school enrolment, and
educational attainment (highest grade reached at school).
Results: There was no significant overall intervention effect on cognitive abilities, but there
was a significant interaction between intervention group and the duration of post-trial
prophylaxis (p ¼ 0.034), with cognitive ability somewhat higher in the intervention group
among children who received no post-trial prophylaxis (treatment effect ¼ 0.2 standard
deviations [SD], 95% confidence interval [CI] 0.03 to 0.5) and among children who received
less than 1 y of post-trial prophylaxis (treatment effect ¼ 0.4 SD, 95% CI 0.1 to 0.8). The
intervention group had higher educational attainment by 0.52 grades (95% CI ¼0.041 to
1.089; p¼ 0.069). School enrolment was similar in the two groups.
Conclusions: The results are suggestive of a long-term effect of malaria prophylaxis on
cognitive function and educational attainment, but confirmatory studies are needed.
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INTRODUCTION
International initiatives to control malaria—such as Roll Back
Malaria and the Global Fund to Fight HIV/AIDS, Tuberculosis
and Malaria—can be justiﬁed in terms of the documented
mortality and morbidity due to this disease. Each year African
children under the age of 5 y suffer between 400 and 900
million acute febrile episodes [1], and between 700,000 and 2.7
million of them die frommalaria [1,2]. In addition, malaria has
a considerable social and economic impact [3]. Such analyses,
however, may underestimate the burden of malarial disease [4]
if they overlook its impact on cognition and education [5,6].
There are few data on which to estimate the burden of
cognitive impairment associated with malaria [7].
Evidence suggests that malaria can impair cognitive
development [8,9]. Cerebral malaria—malaria accompanied
by coma—can cause severe neurological impairment in
survivors, including speech and behavioural disorders, hear-
ing impairment, blindness, epilepsy, hemiplegia, and cerebral
palsy [10]. Less severe impairments in cognitive functions are
also observed in children up to at least 2 y after an episode of
cerebral malaria [11–14]. Few studies, however, have ad-
dressed the effect of malaria on cognitive abilities at the
community level. Two studies have found an association
between repeated malaria episodes and poor performance in
educational tests [15,16]. Only one study has measured the
impact of effective malaria treatment on cognitive function.
This study found no overall effect on cognitive function of
schoolchildren with asymptomatic Plasmodium falciparum
infection 2 wk after antimalarial treatment [17], although
treatment appeared to improve visual memory and ﬁne
motor control in children with the highest pre-treatment
parasitaemia. Overall, such ﬁndings are suggestive of an
association between malaria and cognitive function. Without
supporting data from carefully controlled intervention
studies, however, the potential role of confounding factors
related to both malaria infection and deﬁcits in cognitive
function cannot be excluded. Interventions can also meet the
need for community-level data, as opposed to focusing on
survivors of cerebral malaria. In addition, there is a lack of
evidence on the long-term cognitive effects of malaria, as
studies have tracked survivors of cerebral malaria only into
the early years of primary school. We aimed to address these
gaps by assessing the cognitive abilities and educational
attainment of a cohort of young children who had taken part
in a malaria chemoprophylaxis trial 14–16 y previously [18].
There is growing evidence that the health and nutrition of
young children has a long-term effect on their cognitive
development. For example, Giardia lamblia infection in the
ﬁrst 2 y of life is associated with a lower IQ at age 9 y [19].
Children undernourished in the ﬁrst 2 y of life have lower
IQs, lower educational achievement, and higher levels of
conduct disorders in adolescence than do well-nourished
children [20–23]. Children with iron deﬁciency in the second
year of life are more likely in adolescence to have poor motor,
cognitive, and educational outcomes; anxiety and depression;
and attentional, social, and behavioural problems [24].
Similarly, malaria infection could have a deleterious effect
on cognitive function, as a result of cerebral malaria,
anaemia, or malnutrition [9], which might be alleviated by
effective malaria control programmes. Thus, we hypothesised
that children who had received malaria chemoprophylaxis in
early childhood would have improved cognitive abilities and
educational attainment in late adolescence.
METHODS
Participants
The original malaria chemoprophylaxis trial recruited
children aged 3–59 mo of age living in 15 villages situated
between 32 km to the east and 22 km to the west of the town
www.plosclinicaltrials.org August | 2006 | e190002
Malaria and Cognitive Development
Editorial Commentary
Background: The burden of disease and death from malaria is well
documented, but little is known about the impact of malaria on the
mental development of children and their ability to learn. Evidence from
observational studies suggests episodes of malaria are associated with a
negative impact on mental processes such as language, memory, and
attention. However, there is very little evidence from trials on whether
community-level approaches to malaria prevention can improve mental
and educational development in children. In a trial conducted in the
Gambia between 1985 and 1987, which was reported in The Lancet (21:
1121–1127), young children were allocated either to receive dapsone/
pyrimethamine (a commonly used drug for malaria prevention) or
placebo, for up to four years. At the end of the trial, the drug was then
offered to all children at the study sites. In a follow-up to the original
trial, reported here, the researchers then attempted to trace the original
trial participants and look at various measures relating to mental
development: memory, attention, reasoning, knowledge, language, and
level of schooling reached.
What this trial shows: The investigators found no significant differences
in mental development scores (memory, attention, reasoning, knowl-
edge, and language) between children who had received malaria
prevention during the trial and those who had not, although scores
appeared higher for children who received malaria prevention for the
longest period. However, they did see a significant difference in
schooling level, with children who received malaria prevention during
the trial having achieved just over half a grade higher in school.
Strengths and limitations: The original trial methods ensured that the
two participant groups were comparable on relevant demographic,
household, and educational factors at the start of the trial. Furthermore,
the measures used to compare mental development were appropriate,
validated for African populations, and then further adapted in the groups
being studied. Although only close to half of the original trial
participants could be successfully traced, a sample size calculation shows
that the follow-up study probably had enough power to detect
important effects. However, a major limitation of the study is that once
the main trial was complete, all participants were offered malaria
prevention with dapsone/pyrimethamine. This limits the extent to which
the follow-up study could have detected prevention effects 14 years
later, had they existed. The researchers investigated this by doing
separate analyses based on how long children spent in the trial. They
found a stronger positive effect of malaria prevention on mental
development scores for children who spent longer in the trial (and
therefore got post-trial prevention for a shorter period of time). This
finding supports, but does not conclusively prove, the hypothesis that
malaria prevention enhances mental development.
Contribution to the evidence: This study adds data from a well-
controlled clinical trial to the body of evidence suggesting that malaria
prevention may have beneficial effects on mental and educational
development. Very few previous trials have examined this outcome;
these results need to be confirmed in future studies specifically designed
to test such hypotheses.
The Editorial Commentary is written by PLoS staff, based on the reports of the
academic editors and peer reviewers.
of Farafenni, the Gambia, on the north bank of the River
Gambia, approximately 100 km from the coast. Malaria and
iron deﬁciency are the main causes of anaemia in children in
this area; hookworm is uncommon.
Five of the 15 villages withdrew from the trial before its
completion, due to the death or dismissal of the village health
worker in two villages and inadequate drug supply in the
others. The remaining ten villages were invited to participate
in a follow-up study. Participants qualiﬁed for the current
study if they were eligible to receive placebo or prophylaxis
for three consecutive months in at least one of the three ﬁnal
malaria transmission seasons during the original trial. A total
of 1,190 participants (604 female) of median age 17 y 5 mo
(range 14 y 9 mo to 20 y 3 mo) were eligible for the current
study. Of these, 18% (214) had been present in the original
trial for 1 y, 39% (464) for 2 y, and 43% (512) for 3 y. The
length of time children were present in the original trial
depended on their date of birth and when they moved to or
from the village.
Interventions
Children were allocated systematically by residential com-
pound (a group of households) to receive dapsone/pyrimeth-
amine (Maloprim) or a matching, inert placebo. The
intervention was given fortnightly during the malaria trans-
mission season to all children present in the village in the
eligible age range from April 1984 to March 1988. Compli-
ance was 60% for chemoprophylaxis and 59% for placebo
during the last year of the formal surveillance period [25] and
a little higher 2 y previously. As a result of reductions in
mortality and morbidity attributable to chemoprophylaxis,
dapsone/pyrimethamine was offered to all children of an
eligible age in study villages at the end of the trial in 1988
through a Ministry of Health primary health-care pro-
gramme. Chemoprophylaxis was then sustained during the
malaria transmission season for at least 2 y in study villages
[26], until replaced by insecticide-impregnated bed nets as
the primary method of malaria control in the Gambia.
Children from a 1:5 random selection of compounds were
evaluated approximately 2 mo before the intervention began
and throughout observation periods for the next 4 y. Placebo
and intervention groups in this sub-sample were well
matched for age and ethnic group. Chemoprophylaxis was
highly effective. During two periods of observation [18,25]
overall mortality was reduced by approximately 40% and
malaria-attributable mortality by about 80% in children who
received prophylaxis. In the Farafenni area, children experi-
ence on average one clinical attack of malaria every two rainy
seasons; this was reduced by about 75% in children who
received chemoprophylaxis. The mean packed cell volume
was substantially higher in children who had received
chemoprophylaxis than in those who had received placebo
at the end of both periods of observation (33.9% versus
31.2% for the ﬁrst period and 33.5% versus 31.9% for the
second period), and fewer children who had received
chemoprophylaxis were underweight (,80% weight for
height) at the end of the rainy season (41% versus 59%).
Objectives
The objective of the study was to assess the long-term
educational and cognitive effects of malaria chemoprophy-
laxis in early childhood.
Outcomes
The outcomes of the follow-up study were cognitive function,
educational attainment (highest grade of schooling reached),
and school enrolment.
Assessment of the impact of chemoprophylaxis on educa-
tional performance and cognitive function was not an initial
end-point of the trial. However, because of increasing
interest in the possible effect of malaria on educational
performance and the paucity of information in this area, we
considered it worthwhile to trace as many of the children who
had participated in this trial as possible and to assess their
cognitive ability and past educational performance.
Sample Size
Power calculations indicated that a sample of 550 partic-
ipants would be sufﬁcient to detect a 0.3–standard deviation
(SD) difference between groups with 80% power, assuming an
average of four participants per compound and an intra-
cluster correlation coefﬁcient of 0.2. This effect size is typical
of cognitive effects of other early childhood health and
nutrition interventions [27].
Randomisation
Each compound was allocated a three-digit number in a
sequential manner moving around the village. Compounds
whose number ended in a zero or an even number were
allocated to receive placebo, and those whose number ended
in an odd number received chemoprophylaxis. Further
details of the trial are given in earlier publications [18,25].
Blinding
All ﬁeld staff and participants in the original trial and the
follow-up study were unaware of the allocation to interven-
tion or placebo group.
Procedures
As the study villages are included in the Farafenni Demo-
graphic Surveillance System [28], participants’ records were
checked to ensure that their date of birth and parental names
matched those in the demographic database maintained at
the Medical Research Council.
The follow-up study was approved by the Gambia Govern-
ment and the Medical Research Council Ethics Committee.
Meetings were held in all villages with political leaders and
village heads to explain the objectives and methods of the
study, to answer questions, and to obtain consent for the
study. Written, informed consent was obtained from all
participants or from parents or guardians of those under 18 y
of age. Data collection took place from May to November
2001.
A battery of cognitive tests was administered to partic-
ipants. Three tests measured memory and attention. These
were a digit span test, assessing short-term memory for
strings of orally presented digits (in order of presentation and
then, in a separate test, in reverse order), a categorical ﬂuency
test, assessing the number of animals and food types children
can name in two 1-min sessions, and a visual search test,
assessing the speed at which children identify target pictures
from amongst distracters. There were two tests correspond-
ing to the two constituent factors of general intelligence—
ﬂuid intelligence (inductive reasoning) and crystallised
intelligence (knowledge) [29]. Raven’s Coloured Progressive
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Matrices Test assessed children’s reasoning ability, and a
Gambian adaptation of the Mill Hill Vocabulary Test [30] was
a measure of knowledge. There was also a test of proverb
understanding based on a sub-test of the Wechsler Adult
Intelligence Scale [31] designed to measure verbal ability
using culturally relevant stimuli. With the exception of the
proverbs test, all cognitive tests had been previously validated
with African populations [32], and all tests were adapted for
use with the Mandinka and Wollof groups. For tests of verbal
ability (the vocabulary and proverbs tests), only questions that
were equivalent in the two languages were used. All measures
were piloted extensively and tested for validity and test–retest
reliability, assessed through correlation between scores from
repeated test sessions 1 wk apart. Two tests—the digit span
backwards test and the categorical ﬂuency test (food
section)—were found to have low reliabilities (,0.65) and
were dropped from the test battery. Four cognitive testers
were trained and monitored through the use of test–retest
reliabilities. Training was complete when all testers achieved
acceptable reliability levels (.0.65) in all tests. The test of
proverb understanding was further assessed to ensure that
coding of responses was consistent across the four testers.
Inter-tester reliability, assessed through correlation, was at
least 0.96 for all tester pairs.
Tests were administered in one session lasting around 45
min in a quiet area in one compound in each village. All
testing was done in the child’s language of preference—either
Wollof or Mandinka. Children were fed a sandwich before
testing to reduce the effects of hunger on performance [33].
Socioeconomic, Demographic, Anthropometric, and
Educational Data
Two ﬁeld workers administered a questionnaire to all
participants to obtain basic demographic information and
the educational history of participants and their parents.
Height was measured using a portable stadiometer (CMS
Weighing Equipment, London, United Kingdom) to a pre-
cision of 1 mm. Weight was measured with a mechanical scale.
Field workers were trained in anthropometric assessment. In
addition, data were available from a previous socioeconomic
survey conducted in study villages in 1998. This survey
collected data from one representative in each compound,
following the methodology of a similar survey [28].
Statistical Methods
A statistical analysis plan speciﬁed the primary end-points of
the follow-up study, based on the study protocol. They were
cognitive function, school enrolment, and educational attain-
ment (the highest grade of schooling reached). The outcome
measure for cognitive function was determined as follows.
First, all variables were tested for normality, and one variable
(visual search) was Box-Cox transformed to normality [34]. A
factor analysis using the maximum likelihood method was
performed on the six cognitive function variables: digit span,
categorical ﬂuency (animals), visual search, Raven’s Matrices,
vocabulary, and proverbs. The ﬁrst factor explained 39% of
the variance—the only factor to explain more than one-sixth
of the variance. This factor was subsequently used as the sole
cognitive function outcome variable in analyses, with higher
scores on this variable indicating improved cognitive func-
tion. Factor scores were obtained using the Bartlett method
[35,36]. The factor loadings of the six variables were fairly
similar, ranging from 0.45 to 0.79 (Table S1). The SD of the
outcome variable was 1.1.
Regression analysis of cognitive function scores with
adjustment for covariates was conducted. The ﬁrst analysis
adjusted for variance due to tester and test language. The
second analysis adjusted for the other covariates. Highest
education grade was analysed by both linear regression and
ordinal logistic regression to see whether the results were
model-sensitive [37]. Enrolment in primary school was
analysed by logistic regression.
There were no missing cognitive test data for children
included in the analyses. There were 93 participants with
other missing values in education variables and/or covariates.
For analyses that adjusted for covariates, missing values were
multiply imputed by iterative multiple regression and the
data analysed using multiple imputation methodology [38,39].
On average there were three participants per compound.
Huber-White robust standard errors were estimated and used
in all inferential statistics to allow for the correlation between
participants from the same residential compounds [40].
A secondary analysis examined intervention effects accord-
ing to the number of years of post-trial prophylaxis received.
The length of time eligible for post-trial prophylaxis was a
function of children’s age at the time of prophylaxis and was
independent of children’s allocation to trial arms. Eligibility
for post-trial prophylaxis was not, however, independent of
time on trial—those eligible for the longer periods of post-
trial prophylaxis were generally on trial for a shorter period of
time (see Results for details). The participants were grouped
into four categories according to the number of years for
which they were eligible for post-trial prophylaxis: 0 y, 0 to 1 y,
1 to 2 y, and 2 y or more. The regression analyses of cognitive
function, highest grade of schooling, and enrolment in formal
education were repeated in each of the four categories. The
presence of monotonic trends would be taken as evidence of
dilution of intervention effects by the availability of post-trial
prophylaxis, as indicated by a test of the interaction between
intervention group and duration of post-trial prophylaxis in
their effects on cognitive function. Finally, interaction
between the intervention and gender was explored. All
analyses were conducted using Stata version 8 software
(StataCorp, College Station, Texas, United States).
RESULTS
Participant Flow
The ﬂow of participants is shown in Figure 1. The
proportions of children who were successfully traced and
assessed for cognitive function were similar in the prophy-
laxis and placebo groups (291/605 ¼ 48.1% and 288/585 ¼
49.2%, respectively; p ¼ 0.70).
Baseline Data
The two intervention groups were also similar in terms of age,
gender, ethnicity, duration of both trial participation and
eligibility for post-trial prophylaxis, and several economic
and anthropometric indicators (Table 1). Only a quarter of
fathers and approximately a tenth of mothers had received
formal primary education. Children in the chemoprophylaxis
arm appeared to be more advantaged in terms of father’s
education and, to a lesser extent, mother’s education.
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However, they were less advantaged in that fewer of them had
a radio in their compounds.
Outcomes and Estimation
There were no signiﬁcant differences in the cognitive
function scores between the two arms, with or without
adjustment for covariates (adjusted estimates in Table 2; p .
0.10 for all; the intracluster correlation coefﬁcient for the
cognitive function score was 0.212). The two groups were very
similar in the proportion enrolled in school (unadjusted odds
ratio¼ 1.020, 95% conﬁdence interval [CI] 0.658 to 1.583; p¼
0.928; logistic regression), and adjustment for covariates was
without effect (adjusted estimates in Table 2). However, there
was a signiﬁcant (p ¼ 0.013) interaction between school
enrolment and female gender. In an adjusted model that
included this interaction term, the odds ratios (95% CI) on
the intervention (control ¼ 0 and prophylaxis ¼ 1), gender
(male ¼ 0 and female ¼ 1), and the interaction were 0.674
(0.383 to 1.184), 0.154 (0.087 to 0.272), and 2.773 (1.243 to
6.193). Hence the intervention effect in boys was 0.674 (0.383
to 1.184; p ¼ 0.170) and in girls was 0.674 3 2.773 ¼ 1.869
(0.943 to 3.702; p ¼ 0.073). The prophylaxis appeared to
increase the odds that the girls attended school and decrease
the odds that the boys attended school, though these effects
did not reach statistical signiﬁcance.
The prophylaxis group’s mean educational attainment was
4.47 grades at school compared to the placebo group’s 3.81.
Unadjusted regression analysis gave a mean attainment 0.65
grades higher in the intervention arm (0.023 to 1.276; p¼0.042).
This estimate was reduced slightly to 0.52 (p¼ 0.069; Table 2)
when covariates were included in the analysis. Estimates were
similar using ordinal logistic regression (Table S2).
Ancillary Analyses
Supplementary analyses were conducted, stratiﬁed by num-
ber of years children were eligible for post-trial prophylaxis.
For the cognitive function score, there was a signiﬁcant
interaction between the four sub-groups and the trial
intervention (p ¼ 0.034), with larger treatment effects for
the two groups that spent the longest on trial and received
the least post-trial prophylaxis (Table 3). There was a small
effect (0.264, or, in units of SD, approximately 0.24 SD, 95%
CI 0.03 to 0.51) in the group of individuals that were not
eligible for post-trial prophylaxis and spent 3 y in the trial,
and a somewhat larger effect (0.43 SD, 95% CI 0.10 to 0.77)
among those eligible for less than 1 y of post-trial prophylaxis
and who were in the trial for all 4 y. There was no effect
among those eligible for more than 1 y of post-trial
prophylaxis. For both educational measures, there was no
signiﬁcant interaction between years of post-trial prophylaxis
and treatment, but the pattern of results for the highest grade
reached (Table 3) was similar to that found for cognitive
function, with the largest effects for sub-groups receiving less
than 1 y of post-trial prophylaxis.
Figure 1. Participant Flow in Follow-Up to Chemoprophylaxis Cluster-Controlled Trial
Participant flow in the malaria chemoprophylaxis trial and follow-up 11 y later. Fifteen villages took part in the trial, with treatment allocated systematically by
compound. Follow-up was conducted in the ten villages that completed the trial. Children who completed a whole year of the trial were selected to take part in
the follow-up.
1The village health worker died in one village and was dismissed in another. Drugs were insufficient in three villages.
2Only children participating in at least one complete transmission season were selected for tracing. Some compounds contained both children selected and
children not selected.
3One child refused and one child failed to understand cognitive test instructions in the placebo group. One child refused and two failed to understand
instructions in the prophylaxis group.
*Intervention group allocation was by compound, trial completion was on a village basis, and selection for tracing was conducted for individual children.
DOI: 10.1371/journal.pctr.0010019.g001
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DISCUSSION
Interpretation
The overall pattern of results is suggestive of a positive long-
term effect of the trial prophylaxis on cognitive function
diluted by offering prophylaxis to the placebo group at the
end of the trial. However, as end-of-trial prophylaxis was not
an experimental intervention and was confounded with age
and years on trial, it is not possible to draw unequivocal
conclusions and conﬁrmatory studies are needed.
There were overall treatment effects of borderline signiﬁ-
cance on the educational outcome variables. The prophylaxis
group had 0.52 more years of schooling (95% CI 0.041 to
1.089; p ¼ 0.069). Results suggested that this effect was also
diluted by end-of-trial prophylaxis, although the relationship
between years of schooling and length of post-trial prophylaxis
was non-signiﬁcant. There was no overall difference in school
enrolment; there was a signiﬁcant interaction between gender
and treatment group, but the direction of the effect was
different in boys and girls, with girls in the prophylaxis group
more likely to enrol in school than girls in the placebo group,
and boys less likely. Given international targets of achieving
universal primary education by 2015 and gender equity in
education by 2005, it is critically important that future studies
examine the potential for early childhood malaria protection
to contribute to reaching these education goals.
This study has a number of limitations with implications
for the interpretation of ﬁndings. First, post-trial prophylaxis
may have affected results. If the trial intervention had an
impact on cognitive and educational outcomes, our results
will have underestimated this effect for cohorts who received
post-trial prophylaxis. Unfortunately, the effect of post-trial
prophylaxis cannot be reliably disentangled from that of the
trial intervention. Second, only 50% of target participants
were followed up in this study. Follow-up rates and back-
ground characteristics were similar between treatment arms
in the follow-up sample, suggesting that any treatment effects
found were not artefacts resulting from sample bias. Thus,
our conclusions stand. However, we cannot be certain that
our sample was representative of the original trial population
or that our conclusions apply to those children not followed
up in this study.
Third, assessing long-term educational outcomes was not
an explicit goal of the original trial. Thus, biomedical
outcomes were collected only for a proportion of our study
sample, and no cognitive assessments were made at the end of
the intervention. Such data may have helped clarify the
nature of the effect of prophylaxis on cognition.
.......................................................................................
Table 1. Characteristics of Trial Participants
Characteristic Sub-Category Prophylaxis Placebo
Age at test (years) (n ¼ 579) 17.07 (1.37) 17.07 (1.34)
Female 48.11% (140) 49.65% (143)
Used Wollof in test 27.84% (81) 22.92% (66)
Tester 1 28.52% (83) 27.08% (78)
2 28.52% (83) 24.31% (70)
3 19.59% (57) 23.61% (68)
4 23.37% (68) 25.00% (72)
Father’s education None 22.02% (61) 21.85% (59)
Madrassa 42.60% (118) 55.56% (150)
Primary 22.74% (63) 14.44% (39)
Junior secondary 12.64% (35) 8.15% (22)
Mother’s education None 38.11% (109) 41.30% (114)
Madrassa 48.60% (139) 48.19% (133)
Primary 13.29% (38) 10.51% (29)
Household size (n ¼ 552) 9.35 (5.54) 9.64 (5.72)
Child in compound with
iron roof
29.02% (74) 31.97% (86)
Child in compound with
radio
47.84% (122) 53.16% (143)
Child with at least one missing
outcome or covariate values
17.18% (50) 14.93% (43)
Years on trial (n ¼ 579) 2.99 (0.78) 2.97 (0.80)
Years eligible for post-trial
prophylaxis (n ¼ 579)
0.86 (0.88) 0.89 (0.87)
Child height at follow-up
(centimeters) (n ¼ 561)
160.7 (8.8) 161.8 (9.8)
Child weight at follow-up
(kilograms) (n ¼ 561)
49.6 (9.7) 50.0 (10.7)
Mean (SD) for age, household size, number of years on trial, number of years eligible
for post-trial prophylaxis, height and weight; column percentage (number) for other
variables. Sample size varies due to missing values.
DOI: 10.1371/journal.pctr.0010019.t001..
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Table 2. Cognitive Test and Education Outcomes by Intervention Group
Test/Outome Prophylaxis (n ¼ 291), Mean (SD) Placebo (n ¼ 288), Mean (SD) Regression Estimatesa
Difference (95% CI) p-Value
Cognitive function factor score 0.039 (1.141) 0.039 (1.064) 0.128 (0.052 to 0.308) 0.162
Visual (seconds) 58.74 (29.37) 60.50 (27.90) 2.663 (7.885 to 2.559) 0.316
Raven’s Matrices 9.06 (2.79) 9.02 (2.72) 0.096 (0.362 to 0.553) 0.680
Digit span 5.03 (1.14) 5.01 (1.13) 0.085 (0.085 to 0.256) 0.326
Fluency 14.97 (3.51) 14.65 (3.93) 0.363 (0.192 to 0.919) 0.199
Proverbs 6.35 (3.86) 6.21 (3.73) 0.252 (0.308 to 0.812) 0.376
Vocabulary 13.39 (3.19) 13.26 (3.19) 0.221 (0.297 to 0.739) 0.402
Years at schoolb 4.47 (3.04) 3.81 (2.91) 0.524 (0.041 to 1.089) 0.069
School enrolment 37.1% 36.6% OR ¼ 1.030 (0.643 to 1.650) 0.901
Mean scores for the six tests of cognitive function (and resulting cognitive function factor score) and for two measures of educational attainment for participants in the two
experimental groups: those receiving malaria chemoprophylaxis and those receiving an inert placebo in early childhood, 14–16 y previous to the outcome assessment. Regression
estimates are for the difference in outcomes between the two groups adjusting for socioeconomic variables and, for cognitive tests, identity of tester and language of tests. (Group
differences in years of schooling approached significance; all other group differences were non-significant).
aAdjusted for age at follow-up, gender, father’s education, mother’s education, household size, iron roof, and radio in the compound. Cognitive analyses additionally adjusted for
testers and test language. Linear effect for age and household size; other variables are categorical.
bFor analyses of years at school and school enrolment, 93 observations with missing covariate values were imputed.
DOI: 10.1371/journal.pctr.0010019.t002..
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If treatment effects on cognitive function are genuine, the
mechanisms by which chemoprophylaxis achieved these
effects can be considered. They are most likely to have arisen
from the prevention of cerebral malaria in a small number of
children and the prevention of anaemia and improvement of
nutritional status in a much larger number. Estimates on the
basis of data collected during the period of the trial [18]
indicate that prophylaxis led to around ten (;3%) fewer cases
of cerebral malaria among the children in our sample, at least
40 (;14%) fewer children with anaemia levels of less than
30% packed cell volume, and more than 50 (;19%) fewer
cases of underweight; many more children are likely to have
beneﬁted from a more modest increase in their haemoglobin
and weight. Malnutrition in early childhood has been shown to
have a long-term impact on cognition [19,20,22,23]. The
impact of malaria-induced anaemia on cognitive function is
poorly understood, but iron deﬁciency anaemia, which occurs
in children with malaria, does have a long-term impact on
cognitive function [41,42]. It is also possible that long-term
beneﬁts for children’s health improved their school attend-
ance, which in turn improved cognitive development [9]. The
gender difference in school enrolment, if genuine, could be
explained if parents’ determination to send girls to school is
more vulnerable to setbacks, such as child health problems,
than for boys. A similar explanation was put forward for
gender differences in the effect of preschool nutrition on
school enrolment in Pakistan [43].
Generalisability
The impact on educational attainment may not be replicated
in regions with a higher initial level of primary school
enrolment. Conversely, both parasite prevalence and the
incidence of clinical malaria are relatively low in the Gambia,
and a more marked effect might be observed in an area with a
higher level of transmission.
Overall Evidence
Previous research has found impaired cognitive performance
following severe malaria [11–14] and poorer school perform-
ance following repeated malaria attacks [15,16]. The current
study extends these ﬁndings by assessing cognitive function
and educational attainment after an experimental interven-
tion; ﬁndings are suggestive of a protective effect of malaria
chemoprophylaxis on both outcomes. The results further add
to existing studies by providing some evidence of cognitive
effects of malaria at the population level, rather than just in a
sub-population of cerebral malaria survivors, and by ﬁnding
that such effects persist after 14 y. The study also adds to
ﬁndings associating malaria with poorer performance in
cognitive and educational tests by demonstrating an impact
on the highest grade attained at school, an outcome with
greater relevance for future life success.
In summary, our study is suggestive of a long-term effect on
children’s cognitive development and education. Given the
prevalence of malaria, any effect it has on cognitive function
is likely to amount to a massive cumulative loss across the
world. These results draw further attention to the current
focus on malaria prevention and treatment in young
children, be it by impregnated bed nets, prompt treatment
upon infection, or intermittent presumptive treatment for
children [44–46]. The study also emphasises the need to
investigate the long-term educational and cognitive outcomes
of children currently participating in malaria control trials,
and helps clarify methodology for such investigations.
The ﬁndings also emphasise the potential for health
interventions in early childhood to improve cognitive
function in the long term. To date, the only early childhood
interventions shown to improve long-term cognitive out-
comes are those targeted at malnourished young children
[20,22,23]. More generally, this study adds to a growing body
of research suggesting that one of the most effective ways to
improve a child’s education is by ﬁrst improving their health.
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Table 3. Estimates of Prophylaxis Effect on Cognitive Function and on Years of Schooling, Adjusted for Covariates, by Years of Post-
Trial Prophylaxis
Years of Post-Trial Prophylaxis Years on Trial, Mean (SD) Cognitive Function Years of Schooling
Difference (95% CI) p-Value Regression Coefficient (95% CI) p-Value
0 (n ¼ 159) 3.0 (0.67) 0.264 (0.036 to 0.565) 0.084 0.886 (0.074 to 1.847) 0.070
,1 (n ¼ 130) 4.0 (0.07) 0.478 (0.110 to 0.846) 0.011 1.501 (0.376 to 2.627) 0.009
1–2 (n ¼ 120) 3.2 (0.29) 0.080 (0.475 to 0.315) 0.688 0.032 (1.062 to 0.998) 0.950
.2 (n ¼ 170) 2.1 (0.40) 0.082 (0.396 to 0.232) 0.608 0.353 (0.384 to 1.090) 0.345
Regression estimates for the effect of early childhood malaria chemoprophylaxis on cognitive function and years of schooling completed 14 y later. Estimates are presented in sub-
groups according to the length of post-trial prophylaxis given to participants (in both intervention and placebo groups), determined by age at entering the trial. The sub-groups also
differed according to the number of years on trial. The treatment effect was greatest and was statistically significant where post-trial prophylaxis was moderate (,1 y) and participants
spent longest on trial (4 y). It was of borderline significance where participants received no post-trial prophylaxis and spent 3 y on trial. The treatment effect was diluted and was non-
significant where placebo and intervention groups were both given one or more years of post-trial prophylaxis.
Estimates adjusted for age at follow-up, gender, father’s education, mother’s education, household size, iron roof, and radio in the compound. Cognitive analyses additionally adjusted
for testers and test language. Linear effect for age and household size; other variables are categorical. Ninety-three observations with missing covariate values were imputed. p-Values
and 95% CI are based on robust standard errors.
DOI: 10.1371/journal.pctr.0010019.t003..
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Table S1. Factor Loadings for the Six Cognitive Tests
Found at DOI: 10.1371/journal.pctr.0010019.st001 (27 KB DOC).
Table S2. Estimates of Prophylaxis Effect on Educational Attain-
ment Using Ordinal Logistic Regression
Found at DOI: 10.1371/journal.pctr.0010019.st002 (37 KB DOC).
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